About GAZYVA in previously untreated follicular lymphoma
GAZYVA is a type of antibody therapy that targets and attaches to the CD20 proteins found on follicular lymphoma cells as well as some healthy blood cells.
In people with follicular lymphoma, CD20 may be found in higher than normal amounts.
Once attached to the CD20 protein, GAZYVA is thought to work in different ways, including:
- By helping your own immune system destroy the cancer cells
- By destroying the cancer cells directly
GAZYVA can also harm healthy cells in your body.
Starting treatment with GAZYVA
On the days you receive GAZYVA, you should expect to spend most of the day at the clinic or infusion center.
Your doctor may have you take medications one hour before you begin taking GAZYVA. Your doctor may refer to this kind of medication as premedication.
Common premedications include:
- Steroid medications
Taking the suggested medication before treatment may reduce the
chance of possible side effects during your GAZYVA infusion. Be sure
to check with your medical team about the proper premedication you
should take before receiving GAZYVA.